Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Date:

October 24, 2024

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings that showed enough cash on its balance sheet to fund key clinical trials.

Source link

Cafeteria raises $3M to connect brands with their most opinionated customers: teens

Nobel Laureate Bob Dylan accidentally visited the world’s largest publishing trade fair.

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Recent posts

Lumber prices are at record lows — what that means for buyers and homebuilders

Gold prices break a new record, but may be near a peak

Natural-gas prices have dropped during the hottest summer ever, thanks to Europe

Nvidia’s bonds in demand heading into earnings, as investors eye companies expected to benefit from AI spending

Cava’s successful steak launch beefs up restaurant chain’s earnings

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Elevance Health’s stock tumbles as profit dented by ‘unprecedented’ Medicaid challenges

U.S. investors watch French budget mess amid memories of eurozone debt crisis

Commodity markets fear a repeat of China’s 2015 economic slowdown

Colgate-Palmolive beats profit views, even as prices fall in North America again

Urban Outfitters is departing from its ‘alternative sensibility’ to turn around namesake stores

Michael Burry of ‘Big Short’ fame ups his bets on Chinese Internet stocks

Want solar panels and clean-energy home improvements? Here’s what the IRS paid people for upgrades last year.

Related articles

Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

How this Treasury-market dynamic could lead to the next big leg lower in stocks

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Oil may ‘collapse’ below $50 a barrel in 2025 if this perfect storm hits the market

New investigation rips Amazon’s safety record. That’s not slowing the tech giant’s stock.

U.S. oil prices drop nearly 1% on weak Chinese retail-sales data

UnitedHealth Group CEO says healthcare needs fixing. Start with these 3 problems in claims and patient costs, experts say.

Company

Follow us